ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
Background
The failure of conventional therapies and the propensity for recurrence and metastasis make triple-negative breast cancer (TNBC) a formidable challenge with grim prognoses and diminished survival rates. Immunotherapy, including immune check…